✓ checked
trust me, bro:
here is the receipt.
the claim
Renal toxicity is a dose-limiting side effect of cisplatin treatment.
the verdict
SUPPORTED
the evidence backs this
Recorded sources
12 sources for · 0 against
Is it true that renal toxicity is a dose-limiting side effect of cisplatin treatment?
Yes. Renal toxicity is widely recognized as a major, dose-limiting adverse effect of cisplatin chemotherapy, prompting extensive research into protective adjuncts and mitigation strategies.
Verdict: SUPPORTED · 12 sources for, 0 against · Last checked
The analysis
All retrieved papers uniformly acknowledge or investigate cisplatin-induced nephrotoxicity as a well-established, dose-limiting adverse effect that restricts its clinical use, providing overwhelming support for the claim.
Evidence for · 12
Demonstrates that cisplatin induces significant nephrotoxicity in rats, leading to tubular necrosis and altered renal function.
Get citation
Saad, S. Y. & Al-Rikabi, A. C. (2002). Protection Effects of Taurine Supplementation against Cisplatin-Induced Nephrotoxicity in Rats. doi.org. https://doi.org/10.1159/000048587
See more details
More for · 11
Shows that nephrotoxicity is a major, dose-limiting side effect that often forces the discontinuation of high-dose cisplatin therapy in cancer patients.
Get citation
Hoek, J., Bloemendal, K., Velden, L. V. d., Diessen, J. V., Werkhoven, E. V., Klop, W., & Tesselaar, M. (2016). Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas. doi.org. https://doi.org/10.3390/cancers8020021
Investigates the mechanisms of cisplatin-induced nephrotoxicity and observes significant elevations in serum creatinine and urea following treatment.
Get citation
Najjar, T. A. & Saad, S. Y. (2001). Cisplatin Pharmacokinetics and Its Nephrotoxicity in Diabetic Rabbits. doi.org. https://doi.org/10.1159/000048512
Notes that cisplatin's dose-limiting nephrotoxicity affects up to one third of patients and drives research into protective agents.
Get citation
A, M., A, M., & CV, S. (2026). Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Cisplatin Nephrotoxicity: A Mechanistic Review.. doi.org. https://doi.org/10.34067/kid.0000001194
States that the clinical utility of cisplatin is limited by dose-dependent nephrotoxicity.
Get citation
ME, G., YY, E. B., MH, N., SK, G., & MW, H. (2026). Octreotide mitigates cisplatin-induced nephrotoxicity through coordinated modulation of the miR-34a/SIRT1 axis and downstream apoptotic, inflammatory, and fibrotic pathways.. doi.org. https://doi.org/10.1016/j.lfs.2026.124685
Highlights that the therapeutic use of cisplatin is fundamentally constrained by severe nephrotoxicity.
Get citation
TG, A., KS, A., SK, A., R, A., M, A., N, S., & I, K. (2026). Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.. doi.org. https://doi.org/10.1007/s00210-026-05889-3
Identifies cisplatin-induced nephrotoxicity as a dose-limiting adverse effect that hinders clinical efficacy.
Get citation
H, H., W, Z., H, W., S, Z., S, W., & Y, X. (2026). Artesunate alleviates cisplatin-induced nephrotoxicity by regulating tryptophan metabolism and inhibiting ferroptosis.. doi.org. https://doi.org/10.3389/fphar.2026.1884026
Investigates mechanisms of cisplatin-induced acute kidney injury and evaluates renal dysfunction markers.
Get citation
L, W., J, G., Y, Z., L, Y., D, X., & W, D. (2026). ADP-Ribosylation Factor Guanine Nucleotide Exchange Factor 3 Aggravates Cisplatin-Induced Acute Kidney Injury by Impairing Mitochondrial Fatty Acid Oxidation.. doi.org. https://doi.org/10.1096/fj.202602994r
Examines ferroptosis as a key mechanism underlying cisplatin-induced nephrotoxicity.
Get citation
A, M., Y, I., J, I., R, D., J, Z., D, F., Y, K., Y, I., M, A., H, Y., M, M., & T, K. (2026). The protective role of TRPV4-mediated HSP27 preemptive induction by thermal preconditioning against cisplatin-induced renal tubular injury.. doi.org. https://doi.org/10.1152/ajprenal.00394.2025
Notes that cisplatin causes severe nephrotoxicity by accumulating in renal tubular epithelial cells.
Get citation
T, C., P, D., Y, L., X, C., Z, W., X, L., X, Z., & Y, Z. (2026). Amelioration of Cisplatin Nephrotoxicity by Fe-Pt Coordination Exchange-Triggered Ferroptosis Suppression.. doi.org. https://doi.org/10.1002/adhm.71575
Evaluates treatments for acute kidney injury, noting that cisplatin-induced nephrotoxicity is a primary model for renal damage.
Get citation
M, W., W, P., Y, W., H, Y., Y, L., Q, Z., X, G., Y, L., J, W., Q, L., & W, X. (2026). ASIV Attenuates Cisplatin-Induced Proximal Tubular Injury by Enhancing Mitochondrial Biogenesis and Mitophagy Through the ADRA1A/AMPK/FOXO3A Pathway.. doi.org. https://doi.org/10.1096/fj.202602118r
Get citation
A, P., NC, P., K, W., R, N., A, T., C, J., WK, K., J, T., F, K., & M, C. (2026). Alpha-Mangostin in Acute Kidney Injury: Molecular Mechanisms, Regulated Cell Death, and Translational Opportunities.. doi.org. https://doi.org/10.3390/antiox15080915
What does the evidence say?
All retrieved papers uniformly acknowledge or investigate cisplatin-induced nephrotoxicity as a well-established, dose-limiting adverse effect that restricts its clinical use, providing overwhelming support for the claim.
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work